Trial · NCT01535027
Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
NCT01535027, Phase 4, Completed, Medical University of Vienna
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis. Trials, record NCT01535027. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01535027
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis
- NCT number
- NCT01535027
- Status
- Completed
- Phases
- Phase 4
- Enrollment
- 125 participants, actual
- Lead sponsor
- Medical University of Vienna
- Conditions
- Osteoporosis
- Interventions
- teriparatide, teriparatide and raloxifene, teriparatide and alendronate
- First posted
- 2012-02-17
- Last updated
- 2013-01-03
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Differences in changes of areal lumbar spine BMD between the three treatment groups | Evaluation after 9, 12 and 18 months of TPTD | Primary objective To investigate the changes in lumbar spine BMD of patients among the three treatment groups |
| Secondary | Differences in changes of BMDs and markers of bone turnover among the three treatment groups after 18 months TPTD treatment | Evaluation after 9, 12 and 18 months of TPTD treatment | Secondary objectives * Differences in change of biochemical markers of bone turnover (serum CTX and serum PINP) between treatment groups * Differences in change of the additional DXA results in the hip scan (neck, upper neck, nape, Wards, Troch, shaft, total hip \[g/cm²\]) of patients between treatment groups * To investigate the volumetric changes of vertebral and hip BMD by quantitative computertomography of patients between treatment groups * To investigate safety and tolerability of the treatments |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 24619763 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01535027
GET https://conductscience.org/api/trials/v1/NCT01535027/registered